UBS AM’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $44.2M | Buy |
|
|||||
|
2025
Q2 | $14.4M | Buy |
|
|||||
|
2025
Q1 | $6.66M | Sell |
|
|||||
|
2024
Q4 | $12.2M | Sell |
|
|||||
|
2024
Q3 | $11.8M | Sell |
|
|||||
|
2024
Q2 | $9.71M | Buy |
|
|||||
|
2024
Q1 | $8.97M | Sell |
|
|||||
|
2023
Q4 | $9.65M | Sell |
|
|||||
|
2023
Q3 | $7.73M | Buy |
|
|||||
|
2023
Q2 | $3.68M | Hold |
|
|||||
|
2023
Q1 | $3.68M | Buy |
|
|||||
|
2022
Q4 | $1.23M | Buy |
|
|||||
|
2022
Q3 | $733K | Sell |
|
|||||
|
2022
Q2 | $228K | Buy |
|
|||||
|
2022
Q1 | $339K | Hold |
|
|||||
|
2021
Q4 | $294K | Buy |
|
|||||
|
2021
Q3 | $329K | Hold |
|
|||||
|
2021
Q2 | $494K | Buy |
|
|||||
|
2021
Q1 | $223K | Sell |
|
|||||
|
2020
Q4 | $866K | Sell |
|
|||||
|
2020
Q3 | $693K | Buy |
|
|||||
|
2020
Q2 | $425K | Buy |
|